Clostridium difficile: Not Just a Hospital Infection

Clostridium difficile: Not Just a Hospital Infection

This activity is supported by an educational grant from Merck & Co., Inc.


Author(s)/Faculty: Gary R. Lichtenstein, MD; Ciaran P. Kelly, MD; Darrell S. Pardi, MD, MS; David T. Rubin, MD
Source: Healio - Infectious Disease Education Lab
Type: MonographArticles/Items: 7
Release Date: 10/1/2016Expiration Date: 10/1/2017
Credit Type: CMENumber of Credits: 1.25
Cost: FreeProvider: Vindico Medical Education
There has been an increase in the number of infections caused by various strains of Clostridium difficile (C. difficile). Key factors in the management of the disease include identification of those at risk of infection and recurrence, as well as primary prevention, recurrence prevention, and treatment of infected individuals according to factors such as the severity of the disease and patient history. New therapies with greater efficacy and improved prevention of recurrence are required. In this activity, leading gastroenterologists will discuss the increasing incidence and resistance of C. difficile, as well as compare evidence-based guidelines for the management of C. difficile infection and evaluate therapeutic agents under investigation that may aid in treatment and reduce the occurrence of C. difficile infection.

CME Information

page 1 of 10